A nanobody-based technology can precisely identify and attack lung cancer cells—sparing surrounding healthy tissue. This is the promise of researchers at the Bio-Nano Research Center at the Korea ...
Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes.
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system. Researchers from the Francis Crick ...
A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.
Researchers have discovered a promising new approach to lung cancer treatment. A small molecule called AVJ16 selectively blocks the cancer-driving protein IGF2BP1, halting tumor growth in preclinical ...
Respiratory viruses may activate the growth of dormant cancer cells that have spread to the lungs from elsewhere in the body. Infections like flu seem to spark an inflammatory response that helps the ...
Cells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of soot-like carbon deposits compared to cells taken from people who smoke but do not ...
Veronica Paulus is a former STAT intern supported by the Harvard University Institute of Politics. After patients go into remission, there may still be undetected cancer cells lying dormant through ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback